Total Funding
91
63
Total FundingPost-IPO Equity raised
Growth Score
-3 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
108830
Gemina Labs is a transformative biochemistry firm that develops next-generation testing platforms for detecting pathogens.
- Robert Greene: CTO
- John Davies: CEO
About the Company
Gemina Labs has created and patented a transformative bio-chemistry platform that powers next-generation testing platforms for detecting a wide range of pathogens that affect humans and animals. The tests are quick, inexpensive, and accurate, and they can be self-administered, providing consumers with immediate results. They are developers of novel
surface binders, which are critical to the speed, affordability, and accuracy of the pathogen detection platform.
